ESOT Glasgow
4 al 7 de septiembre de 2011
Sitio web del evento
ESOT 2011 PRELIMINARY PROGRAMME
Sunday 4 September, 2011
Programa científico del evento:
18:10 Opening & Welcome Address ESOT 2011
ESOT 2011 Co-chairs: John Forsythe, Edinburgh, United Kingdom;
Alan Jardine, Glasgow, United Kingdom
18:30 – 19:10 PLENARY SESSION 1
Controlling the immune response
Chairs: John Forsythe, Edinburgh, United Kingdom;
Alan Jardine, Glasgow, United Kingdom
18:30 The challenge of immune tolerance in transplant patients
Lucienne Chatenoud, Paris, France
18:50 Immunosuppressive agents, how to make a choice
Flavio Vincenti, San Francisco, United States
19:10 A meeting with a difference – how you contribute and benefit
Keith Rigg, Nottingham, United Kingdom
19:20 – 20:30 POSTER OPENING & WELCOME EVENT
19:20 – 20:30 MINI ORAL SESSIONS
19:20 – 20:30 RAPID ORAL SESSIONS
Monday 5 September, 2011
08:00 – 09:00 FULL ORAL SESSIONS
08:00 – 09:00 CLINICAL CASES DISCUSSION GROUPS
(selected from abstract submission)
09:00 – 10:30 STATE OF THE ART 1
Improving Patient Outcomes after Liver Transplantation
Chairs: Paolo Muiesan, Birmingham, United Kingdom;
09:00 Minimising immunosuppression in liver transplantation – evidence and prospects for personalised medicine
Alberto Sanchez-Fueyo, Barcelona, Spain (TBC)
09:20 Minimising renal dysfunction in liver transplantation – preventative strategies – how, with what and when
John Lake, Minneapolis, United States
09:40 Minimising cardiovascular risk factors in liver transplantation
– evidence and prospects
Andrew Burroughs, London, United Kingdom
10:00 Quality of Life and Compliance after Liver Transplantation
Patrizia Burra, Padova, Italy
10:20 – 10:30 Q & A
09:00 – 10:30 STATE OF THE ART 2
Cells that rule rejection and tolerance
Chairs: Manuela Battaglia, Milan, Italy;
Thomas Wekerle, Vienna, Austria
09:00 What can zebra fish tell us about key inflammatory events that
drive transplant rejection?
Maggie Dallman, London, United Kingdom
09:20 What cells are actually causing rejection?
Frans Claas, Leiden, The Netherlands
09:40 Regulatory T cells
Matthias Edinger, Regensburg, Germany
10:00 Regulatory B cells
Claudia Mauri, University College London, United Kingdom
10:20 – 10:30 Q & A
09:00 – 10:30 STATE OF THE ART 3 Joint Session ESOT & AST
Challenges in kidney transplantation
Chairs: Josep Campistol, Barcelona,Spain;
Alan Jardine, Glasgow, United Kingdom
09:00 Making the graft last longer
Robert Gaston, Birmigham, United States
09:20 When to use antibody removal strategies
Gunnar Tyden, Stockholm, Sweden
09:40 How to manage BK nephropathy
Rachel Hilton, London, United Kingdom
10:00 Non HLA antibody rejection
Peter Heeger, New York, United States
10:20 – 10:30 Q & A
11:00 – 12:50 FULL ORAL SESSIONS
13:00 – 14:00 RAPID ORAL SESSIONS & POSTER VIEWING
14:00 – 15:30 PLENARY SESSION 2
Making the most of the marginal organ
Chairs: Peter Friend, Oxford, United Kingdom;
Rutger Ploeg, Groningen, The Netherlands
14:00 The marginal organ - information and consent
James Neuberger, Birmigham, United Kingdom
14:20 The science of marginal organs
Jacques Pirenne, Leuven, Belgium
14:40 Putting science into practice: lung
Stig Steen, Lund, Sweden
15:00 Putting science into practice: liver
Joseph Tector, Indianapolis, United States
15:20 – 15:30 Q & A
16:00 – 17:00 NEW CONTROVERSIES 1
The treatment for chronic antibody mediated rejection is…..
Chairs: Anthony Warrens, London, United Kingdom;
Discussants: David Taube, London, United Kingdom
Christophe Legendre, Paris, France
16:40 - 17:00 Discussion
16:00 – 17:00 NEW CONTROVERSIES 2
The solution to the organ shortage is…..
Chairs:Willem Weimar, Rotterdam, The Netherlands;
Beatriz Dominguez-Gil, Madrid, Spain
16:00 Living donation
Arthur Matas, Minneapolis, United States
16:20 Marginal organs
Björn Nashan, Hamburg, Germany
16:40 - 17:00 Discussion
16:00 – 17:00 RAPID ORAL SESSIONS
16:00 – 17:00 MINI ORAL SESSIONS
16:00 – 18:00 FULL ORAL SESSIONS
Tuesday 6 September, 2011
08:00 – 09:00 FULL ORAL SESSIONS
08:00 – 09:00 CLINICAL CASES DISCUSSION GROUPS
(selected from abstract submission)
09:00 – 10:30 STATE OF THE ART 4
Diverse Populations
Chairs: Willem Weimar, Rotterdam, The Netherlands;
Gabriel Danovitch, Los Angeles, United States
09:00 Organ donation and transplantation: realities for minority ethnic groups
Gurch Randhawa, Luton, United Kingdom
09:20 Social factors and the availability of living kidney donation in
diverse populations
Joke Roodnat, Rotterdam, The Netherlands
09:40 Increasing the deceased organ donation rate among immigrant populations
Teresa Pont-Castellana, Barcelona, Spain
10:00 – 10:30 Q & A
09:00 – 10:30 STATE OF THE ART 5
The pancreas/islet donor: new developments
Chairs:Thierry Berney, Geneva, Switzerland;
Johann Pratschke, Innsbruck, Austria
09:00 DCD donors in whole pancreas transplantation
Peter Friend, Oxford, United Kingdom
09:20 Expanding the donor pool for whole pancreas transplantation
Hans Schlitt, Regensburg, Germany
09:40 Donor strategies to improve the outcome of islet transplantation
Bernhard Hering, Minneapolis, United States
10:00 Solitary whole pancreas versus islets: is it time for a clinical trial?
François Pattou, Lille, France
10:20 – 10:30 Q & A
09:00 – 10:30 STATE OF THE ART 6
Biomarkers of Tolerance/Rejection
Chairs: Lorna Marson, Edinburgh, United Kingdom;
Kathryn Wood, Oxford, United Kingdom
09:00 Omics, heat-maps and gene expression profiles:
What they are and what they mean
Minnie Sarwal, United States
09:20 In vitro assays as biomarkers for rejection and engraftment
Maria HernandezFuentes, London, United Kingdom
09:40 Biomarkers: How to model in vivo cellular responses
Alberto Sanchez-Fueyo, Barcelona, Spain
10:00 Biomarkers: New techniques in the laboratory
Robert Lechler, London, United Kingdom
10:20 – 10:30 Q & A
11:00 – 12:50 FULL ORAL SESSIONS
13:00 – 14:00 RAPID ORAL SESSIONS
14:00 – 15:30 PLENARY SESSION 3
Transplantation tomorrow
Chairs: Jean-Micheal Dubernard, Lyon, France;
Robert Gaston, Birmigham, United States
14:00 Composite Tissue Transplantation
Stefan Schneeberger, Innsbruck, Austria
14:20 Tissue Engineering - beyond the trachea
Doris Taylor, Minneapolis, United States
14:40 Minimising the immune response – what is the current science?
Carla Baan, Rotterdam, The Netherlands
15:00 Xenotransplantation - still the future?
Emanuele Cozzi, Padova, Italy
16:00 – 17:00 NEW CONTROVERSIES 3
The big advances in transplantation have come from….
Chairs: Keith Rigg, Nottingham, United Kingdom;
Björn Nashan, Hamburg, Germany
16:00 The randomized controlled trial
Henrik Ekberg, Malmo, Sweden
16:20 Unrandomized innovation
16:40 - 17:00 Discussion
16:00 – 17:00 NEW CONTROVERSIES 4
Organ allocation should be based on…
Chairs: Chris Watson, Cambridge, United Kingdom;
Jan Lerut, Leuven, Belgium
16:00 Fairness / equity
Assya Pascalev, Sofia, Bulgaria
16:20 Transplant benefit
Alexander Gimson, Cambridge, United Kingdom
16:40 - 17:00 Discussion
16:00 – 17:00 RAPID ORAL SESSIONS
16:00 – 17:00 MINI ORAL SESSIONS
16:00 – 17:00 FULL ORAL SESSIONS
Wednesday 7 September, 2011
08:00 – 09:00 FULL ORAL SESSIONS
08:00 – 09:00 CLINICAL CASES DISCUSSION GROUPS
(selected from abstract submission)
09:00 – 10:30 STATE OF THE ART 7
Thoracic transplantation from non-heart beating donors
Chairs:Nicholas R. Banner, London, United Kingdom;
Dirk Van Raemdonck, Leuven, Belgium
09:00 NHBD lung transplantation: how far can we go?
Michiel Erasmus, Groningen, The Netherlands
09:20 NHBD heart transplantation: fiction or reality?
Steve Large, Cambridge, United Kingdom
09:40 Machine perfusion for lung transplantation
Karen Redmond, London United Kingdom
10:00 Machine perfusion for heart transplantation
Olivier Van Caenegem, Leuven, Belgium
10:20 Q & A
09:00 – 10:30 STATE OF THE ART 8
Optimizing organ quality
Chairs: Benoit Barrou, Paris, France;
Robert Porte, Groningen, The Netherlands
09:00 Ischaemic preconditioning
Pierre Clavien, Zurich, Switzerland
09:20 Normothermic recirculation
Juan Carlos García-Valdecasas, Barcelona, Spain
09:40 Modifying ischemia reperfusion injury
Stefan Tullius, Boston, United States
10:00 Machine liver perfusion
Rutger Ploeg, Groningen, The Netherlands
10:20 Q & A
09:00 – 10:30 STATE OF THE ART 9 Joint ESOT EFI BSHI Session
Histocompatibility & Immunogenetics
09:00 Current techniques for Clinical H&I; testing
Taylor Craig, Cambridge, United Kingdom
09:20 H&I; testing to support patient care
Robert Bray, Atlanta, United States
09:40 H&I; testing and outcome in transplantation – CTS data
Gerhard Opelz, Heidelberg, Germany
10:00 Future developments for H&I; support of clinical transplantation
Frans Claas, Leiden, The Netherlands
10:20 Q & A
11:00 – 13:30 PLENARY SESSION 4 What's hot - What's new
Presidential - Best Abstracts presentation -Awards Ceremony
11:00 Presidential address
ESOT President elect
11:15 Honorary Membership celebration:
Kathryn Wood, past-Councilor of ESOT, past-President of TTS,
introduces
Honorary Member Leslie Brent, United Kingdom, United Kingdom
Jan Lerut, past-President of ESOT, introduces
Honorary Member Göran Klintmalm, Dallas, United States
11:35 What’s hot, what’s new in clinical transplantation?
Steve Wigmore, Edinburgh, United Kingdom
11:55 What’s hot, what’s new in basic science?
Olivier Thaunat, Lyon, France
12:15 – 13:05 Best Oral presentations – Biotest Clinical and Basic Science Awards
13.05 – 13.30 Awards & Grants Ceremony
Closing
| Tweet |
|
Blink
Deliciuos
Google
Meneame
Google Buzz
MSN Reporter
MySpace
Yahoo Buzz it!